Zangerle John Adam 4

What Happened John Adam Zangerle, STERIS’s Senior Vice President, General Counsel and Secretary, received equity compensation on June 2, 2026: 4,359 ordinary shares were granted/issued and 15,200 derivative securities (an option-style award) were granted at $0.00. Separately, 846 restricted shares vested on June 2, 2026, and 247 of those vested shares were withheld to cover taxes (code F), valued at $209.76 each for a total tax withholding of $51,811.

Key Details

• Transaction date: June 2, 2026. Grant entries reported as code A (award/grant); tax withholding reported as code F.
• Withheld shares: 247 shares withheld from 846 vested restricted shares; withholding value = $51,811 (NYSE close $209.76).
• Derivative award exercisability (per filing): 15,200 becomes exercisable 3,800 on each of June 2, 2027; June 2, 2028; June 4, 2029; and June 3, 2030.
• Restricted-share schedule (footnote): As of June 2, 2026, 10,867 ordinary shares are restricted with portions lapsing on specified dates between June 2026 and June 2029.
• Shares owned after transaction: not specified in the provided filing excerpt.
• Filing timeliness: no late filing flag indicated in the provided Form 4.

Context

• The transaction is compensation-based (awards/options), not an open-market purchase or sale; the 247-share entry is a tax withholding (code F), not an independent sale.
• The 15,200 “derivative” grant is an option-like award with a multi-year exercisability schedule (see Key Details). Such awards reflect company compensation rather than an executive purchasing stock; they typically vest/exercise over time.
• For retail investors: awards and withholdings are routine executive compensation actions and do not by themselves signal an insider buying or selling in the open market.